April 25th 2024
A retrospective study challenges preoperative withholding of GLP-1 RAs in diabetes patients undergoing surgery, citing no increased risk of postoperative respiratory complications.
Top FDA Approvals in Diabetes Care from the First Half of 2022
July 1st 2022With the first 6 months of 2022 behind us, Endocrinology Network has compiled a list of the top approvals in diabetes care from the first half of the year. The list includes multiple approvals for CGM, a first-in-class agent, and an increased dose of a popular GLP-1 RA.
Most PCPs Forgo Fundoscopic Exams for Diabetic Retinopathy in T2D Patients
June 30th 2022An analysis from Duke University School of Medicine suggests few PCPs were performing fundoscopy to identify diabetic retinopathy in patients with type 2 diabetes and even those who did were often accurate just 63% of the time.
Study Compares Fracture Risk Among Antidiabetes Medication Regimens
June 27th 2022An analysis of real-world data from more than 6500 patients suggests insulin users had a greater risk of fracture than patients using metformin, but this became attenuated among patients using a combination of insulin and metformin.
Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, and Misdiagnosis of T1D
June 24th 2022In this episode, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss their experiences with prescribing tirzepatide (Mounjaro) and what issues patients have encountered, the prospect of new biosimilar insulins that may be coming to the market, and the misdiagnosis of type 1 diabetes in adult patients.
Annual Wellness Visits Linked to Lower Risk of Amputation in Type 2 Diabetes
June 21st 2022An analysis of data from Medicare Fee-for-Service beneficiaries suggests patients attending annual wellness visits were 36% less likely to require lower limb amputation than their counterparts who did not attend an annual wellness visit that year.
Prediabetes Not as Benign as Once Believed, Associated with Increased Risk of Heart Attacks
June 17th 2022An analysis of the National Inpatient Sample details the statistically significant increases in the risk of experiencing myocardial infarction, PCI, or CABG in patients with prediabetes compared to their normoglycemic counterparts.
In Pediatric T1D, Race, Income, & Insurance Type Remain Significant Barriers to Insulin Pump Use
June 14th 2022An analysis of the SEARCH for Youth in Diabetes presented at ENDO 2022 details historic and contemporary disparities in insulin pump use for pediatric type 1 diabetes based on racial/ethnic background, household income, and insurance type.
Diabetes Dialogue: Inside ADA 2022, with Diana Isaacs, PharmD, and Natalie Bellini, DNP
June 10th 2022In the fourth and final episode from ADA 2022, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the meeting from their perspectives as a clinical pharmacy specialist and a nurse practitioner, including their picks for the most exciting advances in diabetes technology to come from the year’s largest diabetes meeting.
Diabetes Dialogue: Barriers & Inequities to Care, with Jasmine Gonzalvo, PharmD
June 10th 2022In the third special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, Jasmine Gonzalvo, PharmD, joins hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, to discuss prevailing barriers in diabetes management, including access to new pharmacologic agents as well as newer diabetes technologies.
Diabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE
June 8th 2022In our second special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, hosts Drs. Diana Isaacs and Natalie Bellini are joined by Gary Scheiner, MS, CDE. Clinical director of Integrated Diabetes Services, author of multiple books, including Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin, and former Diabetes Educator of the Year, Scheiner joins Diabetes Dialogue to provide a deep dive into the largest diabetes meeting of the year from the view of a diabetes care and education specialist.